Total Payments
$7,848
2024 Payments
$1,430
Companies
30
Transactions
454
Medicare Patients
23,174
Medicare Billing
$3.1M
Payment Breakdown by Category
Food & Beverage$7,245 (92.3%)
Education$582.53 (7.4%)
Other$21.10 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,245 | 445 | 92.3% |
| Education | $582.53 | 8 | 7.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $21.10 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,618 | 106 | $0 (2024) |
| Janssen Biotech, Inc. | $1,203 | 62 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $955.14 | 50 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $667.25 | 37 | $0 (2024) |
| PFIZER INC. | $488.55 | 33 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $483.61 | 18 | $0 (2024) |
| Amgen Inc. | $415.14 | 23 | $0 (2024) |
| Lilly USA, LLC | $399.45 | 25 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $269.10 | 13 | $0 (2024) |
| Dermavant Sciences, Inc. | $214.85 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,430 | 74 | ABBVIE INC. ($332.92) |
| 2023 | $1,659 | 92 | Janssen Biotech, Inc. ($443.75) |
| 2022 | $1,392 | 92 | ABBVIE INC. ($418.79) |
| 2021 | $884.19 | 58 | AbbVie Inc. ($252.73) |
| 2020 | $609.98 | 37 | Janssen Biotech, Inc. ($189.94) |
| 2019 | $1,132 | 50 | Novartis Pharmaceuticals Corporation ($332.83) |
| 2018 | $354.91 | 24 | Lilly USA, LLC ($82.68) |
| 2017 | $385.09 | 27 | PFIZER INC. ($81.84) |
All Payment Transactions
454 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $33.14 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $26.93 | General |
| Category: Inflammation | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Inflammation | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Dermatology | ||||||
| 11/01/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: DERMATOLOGY | ||||||
| 10/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $3.70 | General |
| Category: Dermatology | ||||||
| 10/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $27.71 | General |
| Category: Immunology | ||||||
| 10/09/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $15.86 | General |
| 09/26/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Dermatology | ||||||
| 09/25/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $25.81 | General |
| Category: Immunology | ||||||
| 09/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $25.95 | General |
| Category: DERMATOLOGY | ||||||
| 09/11/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological), BLU-U | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Dermatology | ||||||
| 09/03/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: DERMATOLOGY | ||||||
| 08/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Immunology | ||||||
| 08/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Immunology | ||||||
| 08/20/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: DERMATOLOGY | ||||||
| 08/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Odomzo (Drug), BLU-U | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 5,366 | 17,092 | $2.3M | $1.3M |
| 2022 | 29 | 6,482 | 17,861 | $2.3M | $1.2M |
| 2021 | 30 | 5,863 | 8,814 | $1.1M | $299,028 |
| 2020 | 36 | 5,463 | 11,195 | $1.2M | $301,546 |
Total Patients
23,174
Total Services
54,962
Medicare Billing
$3.1M
Procedure Codes
123
All Medicare Procedures & Services
123 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3245 | Injection, tildrakizumab, 1 mg | Office | 2023 | 30 | 9,300 | $1.4M | $1.0M | 75.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,230 | 1,436 | $243,502 | $83,238 | 34.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 971 | 1,117 | $138,584 | $40,378 | 29.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 207 | 236 | $56,791 | $20,061 | 35.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 297 | 312 | $58,015 | $19,902 | 34.3% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 219 | 237 | $54,627 | $19,223 | 35.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 471 | 489 | $51,468 | $15,177 | 29.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 181 | 181 | $38,117 | $12,766 | 33.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 440 | 567 | $78,108 | $12,281 | 15.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 622 | 2,361 | $59,025 | $10,402 | 17.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 126 | 128 | $26,581 | $8,811 | 33.1% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 21 | 25 | $19,539 | $7,580 | 38.8% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 52 | 70 | $19,116 | $6,204 | 32.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 41 | 49 | $16,217 | $5,470 | 33.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 121 | 121 | $16,412 | $5,193 | 31.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 31 | 34 | $10,576 | $3,844 | 36.3% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 15 | 16 | $8,962 | $3,457 | 38.6% |
| 69100 | Biopsy of ear | Office | 2023 | 44 | 50 | $8,914 | $2,671 | 30.0% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 18 | 18 | $6,025 | $2,417 | 40.1% |
| 96567 | Application of light to destroy precancer skin growth | Office | 2023 | 21 | 24 | $5,972 | $2,216 | 37.1% |
| 11105 | Punch biopsy, each additional skin growth | Office | 2023 | 40 | 51 | $5,552 | $2,209 | 39.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 52 | 61 | $5,642 | $2,200 | 39.0% |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 16 | 16 | $4,930 | $1,540 | 31.2% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 11 | 11 | $4,981 | $1,001 | 20.1% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 13 | 13 | $3,170 | $951.55 | 30.0% |
About Dr. Halden Ford, M.D
Dr. Halden Ford, M.D is a Dermatology healthcare provider based in Paducah, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1396747846.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Halden Ford, M.D has received a total of $7,848 in payments from pharmaceutical and medical device companies, with $1,430 received in 2024. These payments were reported across 454 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($7,245).
As a Medicare-enrolled provider, Ford has provided services to 23,174 Medicare beneficiaries, totaling 54,962 services with total Medicare billing of $3.1M. Data is available for 4 years (2020–2023), covering 123 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Paducah, KY
- Active Since 08/15/2005
- Last Updated 09/20/2021
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1396747846
Products in Payments
- TREMFYA (Drug) $891.17
- DUPIXENT (Biological) $661.99
- RINVOQ (Biological) $588.83
- COSENTYX (Biological) $577.91
- TALTZ (Drug) $365.77
- Otezla (Drug) $343.02
- SKYRIZI (Biological) $343.00
- HUMIRA (Biological) $316.70
- EUCRISA (Drug) $313.46
- Humira (Biological) $297.39
- Sotyktu (Drug) $269.10
- COSENTYX (Drug) $265.41
- VTAMA (Drug) $214.85
- ILUMYA (Biological) $203.56
- CIBINQO (Drug) $175.09
- ADBRY (Biological) $173.43
- Tremfya (Drug) $167.28
- REMICADE (Biological) $144.97
- Enbrel (Biological) $91.54
- LIBTAYO (Biological) $90.22
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.